These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 20537446)

  • 1. [Kawasaki disease in adult patients].
    Sève P; Lega JC
    Rev Med Interne; 2011 Jan; 32(1):17-25. PubMed ID: 20537446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
    Newburger JW; Takahashi M; Gerber MA; Gewitz MH; Tani LY; Burns JC; Shulman ST; Bolger AF; Ferrieri P; Baltimore RS; Wilson WR; Baddour LM; Levison ME; Pallasch TJ; Falace DA; Taubert KA;
    Pediatrics; 2004 Dec; 114(6):1708-33. PubMed ID: 15574639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
    Newburger JW; Takahashi M; Gerber MA; Gewitz MH; Tani LY; Burns JC; Shulman ST; Bolger AF; Ferrieri P; Baltimore RS; Wilson WR; Baddour LM; Levison ME; Pallasch TJ; Falace DA; Taubert KA; ; ; ;
    Circulation; 2004 Oct; 110(17):2747-71. PubMed ID: 15505111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting Kawasaki disease: a state-of-the-art review.
    Dietz SM; van Stijn D; Burgner D; Levin M; Kuipers IM; Hutten BA; Kuijpers TW
    Eur J Pediatr; 2017 Aug; 176(8):995-1009. PubMed ID: 28656474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM; Silverman ED; McCrindle BW; Yeung RS
    J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Kawasaki disease: what you need to know].
    Bajolle F; Laux D
    Arch Pediatr; 2012 Nov; 19(11):1264-8. PubMed ID: 22921712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kawasaki disease in adults: report of 10 cases.
    Gomard-Mennesson E; Landron C; Dauphin C; Epaulard O; Petit C; Green L; Roblot P; Lusson JR; Broussolle C; Sève P
    Medicine (Baltimore); 2010 May; 89(3):149-158. PubMed ID: 20453601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Six Kawasaki disease patients with acute coronary artery thrombosis].
    Zhou SL; Luo JP; Qi YQ; Liang YG; Wang W; Gong FQ
    Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):925-9. PubMed ID: 24495764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kawasaki disease in Sicily: clinical description and markers of disease severity.
    Maggio MC; Corsello G; Prinzi E; Cimaz R
    Ital J Pediatr; 2016 Nov; 42(1):92. PubMed ID: 27806720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Necrotic lesions of the face in Kawasaki disease].
    Kourda M; Bouaziz A; Tougourti MN
    Arch Pediatr; 2010 Dec; 17(12):1667-9. PubMed ID: 20884182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with development of coronary artery aneurysms after Kawasaki disease are similar for those treated promptly and those with delayed or no treatment.
    Downie ML; Manlhiot C; Collins TH; Chahal N; Yeung RSM; McCrindle BW
    Int J Cardiol; 2017 Jun; 236():157-161. PubMed ID: 28089146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kawasaki Disease: Beyond IVIG and Aspirin.
    Moussa T; Wagner-Weiner L
    Pediatr Ann; 2019 Oct; 48(10):e400-e405. PubMed ID: 31609999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease.
    Bal AK; Prasad D; Umali Pamintuan MA; Mammen-Prasad E; Petrova A
    Pediatr Neonatol; 2014 Oct; 55(5):387-92. PubMed ID: 24636168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and late coronary outcomes in 1073 patients with Kawasaki disease with and without intravenous γ-immunoglobulin therapy.
    Lin MT; Sun LC; Wu ET; Wang JK; Lue HC; Wu MH
    Arch Dis Child; 2015 Jun; 100(6):542-7. PubMed ID: 25564534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease.
    Berdej-Szczot E; Małecka-Tendera E; Gawlik T; Firek-Pędras M; Szydłowski L; Gawlik A
    Kardiol Pol; 2017; 75(3):261-266. PubMed ID: 27995598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunctive therapies in Kawasaki disease.
    Tremoulet AH
    Int J Rheum Dis; 2018 Jan; 21(1):76-79. PubMed ID: 29076637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocarditis and Kawasaki disease.
    Dionne A; Dahdah N
    Int J Rheum Dis; 2018 Jan; 21(1):45-49. PubMed ID: 29105303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary artery lesions and the increasing incidence of Kawasaki disease resistant to initial immunoglobulin.
    Kibata T; Suzuki Y; Hasegawa S; Matsushige T; Kusuda T; Hoshide M; Takahashi K; Okada S; Wakiguchi H; Moriwake T; Uchida M; Ohbuchi N; Iwai T; Hasegawa M; Ichihara K; Yashiro M; Makino N; Nakamura Y; Ohga S
    Int J Cardiol; 2016 Jul; 214():209-15. PubMed ID: 27070994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kawasaki disease: a comprehensive review of treatment options.
    Patel RM; Shulman ST
    J Clin Pharm Ther; 2015 Dec; 40(6):620-5. PubMed ID: 26547265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kawasaki disease with severe cardiac sequelae: lessons from recent New Zealand experience.
    Wilson N; Heaton P; Calder L; Nicholson R; Stables S; Gavin R
    J Paediatr Child Health; 2004; 40(9-10):524-9. PubMed ID: 15367145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.